Geron to Present at the Needham Healthcare Conference
March 21, 2018 07:30 ET
|
Geron Corporation
MENLO PARK, Calif., March 21, 2018 (GLOBE NEWSWIRE) -- Geron Corporation (Nasdaq:GERN) today announced that John A. Scarlett, M.D., President and Chief Executive Officer, is scheduled to present at...
Geron Corporation Reports Fourth Quarter and Annual 2017 Financial Results and Recent Events
March 16, 2018 16:10 ET
|
Geron Corporation
MENLO PARK, Calif., March 16, 2018 (GLOBE NEWSWIRE) -- Geron Corporation (Nasdaq:GERN) today reported financial results for the fourth quarter and year ended December 31, 2017 and recent events. ...
Geron Announces Conference Call to Discuss Fourth Quarter and Annual 2017 Financial Results
February 22, 2018 16:05 ET
|
Geron Corporation
MENLO PARK, Calif., Feb. 22, 2018 (GLOBE NEWSWIRE) -- Geron Corporation (Nasdaq:GERN) will announce its financial results for the fourth quarter and year ended December 31, 2017, on Friday, March...
Geron Reports Imetelstat Presentations at American Society of Hematology Annual Meeting
December 12, 2017 07:30 ET
|
Geron Corporation
Imetelstat Clinical Data from Part 1 of IMerge in Myelodysplastic Syndromes (MDS) Presented Analyst and Investor Meeting and Webcast at 8:30 a.m. ET on December 19, 2017 MENLO PARK, Calif., Dec. ...
Geron to Host Analyst and Investor Meeting and Webcast on December 19, 2017
December 06, 2017 07:30 ET
|
Geron Corporation
MENLO PARK, Calif., Dec. 06, 2017 (GLOBE NEWSWIRE) -- Geron Corporation (Nasdaq:GERN) today announced that the company’s analyst and investor meeting to discuss imetelstat clinical data will take...
Geron Announces First Patient Dosed in Expanded Part 1 of IMerge Clinical Trial in Myelodysplastic Syndromes
November 20, 2017 07:30 ET
|
Geron Corporation
MENLO PARK, Calif., Nov. 20, 2017 (GLOBE NEWSWIRE) -- Geron Corporation (Nasdaq:GERN) today announced that the first patient has been dosed in the expanded Part 1 of IMerge, the ongoing Phase 2/3...
Geron Announces November Investor Conference Presentation Webcasts
November 07, 2017 07:30 ET
|
Geron Corporation
MENLO PARK, Calif., Nov. 07, 2017 (GLOBE NEWSWIRE) -- Geron Corporation (Nasdaq:GERN) today announced that John A. Scarlett, M.D., President and Chief Executive Officer, is scheduled to present at...
Geron Announces Presentations at American Society of Hematology Annual Meeting
November 01, 2017 09:05 ET
|
Geron Corporation
MENLO PARK, Calif., Nov. 01, 2017 (GLOBE NEWSWIRE) -- Geron Corporation (Nasdaq:GERN) today announced that four abstracts related to the telomerase inhibitor imetelstat have been accepted for...
Geron Announces Fast Track Designation Granted to Imetelstat for Lower Risk Myelodysplastic Syndromes
October 31, 2017 07:30 ET
|
Geron Corporation
MENLO PARK, Calif., Oct. 31, 2017 (GLOBE NEWSWIRE) -- Geron Corporation (Nasdaq:GERN) today announced that the United States Food and Drug Administration (FDA) has granted Fast Track designation to...
Geron Announces Conference Call to Discuss Third Quarter 2017 Financial Results
October 25, 2017 07:30 ET
|
Geron Corporation
MENLO PARK, Calif., Oct. 25, 2017 (GLOBE NEWSWIRE) -- Geron Corporation (Nasdaq:GERN) will announce its financial results for the third quarter ended September 30, 2017, on Wednesday, November 1,...